Novel transcription from the Epstein-Barr virus terminal EcoRI fragment, DIJhet, in a nasopharyngeal carcinoma

Transcription of Epstein-Barr virus (EBV) genes in epithelial tissue, one of the two principal cell types infected by EBV, is not well characterized. EBV transcription in a nasopharyngeal carcinoma established in nude mice, C15, has been analyzed by using strand-specific RNA probes and sequence analysis of a C15 cDNA library. In C15, two equally abundant mRNAs of 3.7 and 2.8 kilobases (kb) are encoded by the sequences that encode latent membrane protein (LMP). Hybridization with probes specific for the 3' end of the LMP mRNA to Northern (RNA) blots and sequence analysis of cDNAs representing the messages indicated that the 3.7- and 2.8-kb mRNAs are 3' coterminal. Sequence analysis of additional cDNAs revealed an mRNA that is spliced identically to the LMP mRNA but is initiated 5' to the promoter for LMP. A probe representing the sequences contained within the cDNA which are 5' to the LMP promoter identified the 3.7-kb mRNA in C15 and a low-abundance 3.7-kb mRNA in B95-8 RNA. These data indicate that transcription of the LMP-encoding sequences is complex and that LMP can be expressed from an additional RNA in both nasopharyngeal carcinoma and lymphoid cells. Hybridization with BamHI-A identified a predominant 4.8-kb mRNA and two less abundant larger-molecular-weight mRNAs transcribed in C15. These mRNAs are consistently expressed in all passages in nude mice of the C15 tumor. Hybridization with strand-specific probes and sequence analysis of three cDNAs revealed that these mRNAs are transcribed from left to right. Sequence analysis of cDNAs representing the 3' end of the mRNAs identified an open reading frame that could potentially encode a protein of 174 amino acids. In situ hybridization of a 35S-labeled RNA probe homologous to the BamHI-A cDNA to tissue sections revealed that the BamHI-A mRNA is not focally expressed and is transcribed in all cells within the C15 tumor. Linear forms of EBV DNA were not detected in any of the C15 tumors, and replicative viral antigens have not been detected. These data suggest that the C15 tumor represents a latently infected tumor and that the transcription from BamHI-A, which is expressed in all cells, is not associated with virus replication.

[1]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[2]  I. Ernberg,et al.  EBV gene expression in an NPC‐related tumour. , 1989, The EMBO journal.

[3]  M. Lipinski,et al.  Establishment and characterization of three transplantable EBV‐containing nasopharyngeal carcinomas , 1988, International journal of cancer.

[4]  E. Kieff,et al.  The truncated form of the Epstein-Barr virus latent-infection membrane protein expressed in virus replication does not transform rodent fibroblasts , 1988, Journal of virology.

[5]  B. Barrell,et al.  Sequence analysis of Raji Epstein-Barr virus DNA. , 1988, Virology.

[6]  T. Tursz,et al.  Epstein-Barr virus gene expression in nasopharyngeal carcinoma. , 1988, The Journal of general virology.

[7]  M. Perricaudet,et al.  A spliced Epstein‐Barr virus gene expressed in immortalized lymphocytes is created by circularization of the linear viral genome. , 1988, The EMBO journal.

[8]  M. Perricaudet,et al.  A promoter for the highly spliced EBNA family of RNAs of Epstein-Barr virus , 1987, Journal of virology.

[9]  W. Martin,et al.  Epstein-Barr virus-specific transcription in normal and malignant nasopharyngeal biopsies and in lymphocytes from healthy donors and infectious mononucleosis patients. , 1987, The Journal of general virology.

[10]  A. Huang,et al.  The differentiated form of nasopharyngeal carcinoma contains epstein‐barr virus DNA , 1987, International journal of cancer.

[11]  N. Raab-Traub,et al.  The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation , 1986, Cell.

[12]  K. Calame,et al.  Clonal origins of lymphoproliferative disease induced by Epstein-Barr virus , 1986, Journal of virology.

[13]  E. Kieff,et al.  An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells , 1985, Cell.

[14]  J. Strominger,et al.  Analysis of the transcript encoding the latent Epstein-Barr virus nuclear antigen I: a potentially polycistronic message generated by long-range splicing of several exons. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[15]  Robert Walgate,et al.  Proliferation , 1985, Nature.

[16]  B. Barrell,et al.  Two related but differentially expressed potential membrane proteins encoded by the EcoRI Dhet region of Epstein-Barr virus B95-8 , 1985, Journal of virology.

[17]  D. Melton,et al.  Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter. , 1984, Nucleic acids research.

[18]  E. Kieff,et al.  Nucleotide sequence of an mRNA transcribed in latent growth-transforming virus infection indicates that it may encode a membrane protein , 1984, Journal of virology.

[19]  C. Yang,et al.  Epstein-Barr virus transcription in nasopharyngeal carcinoma , 1983, Journal of virology.

[20]  B. Hoffman,et al.  A simple and very efficient method for generating cDNA libraries. , 1983, Gene.

[21]  R. W. Davis,et al.  Efficient isolation of genes by using antibody probes. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[22]  E. Kieff,et al.  Epstein-Barr virus RNA. V. Viral RNA in a restringently infected, growth-transformed cell line , 1980, Journal of virology.

[23]  W. Rutter,et al.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. , 1979, Biochemistry.

[24]  B. Sugden,et al.  The structure of the termini of the DNA of Epstein-Barr virus , 1979, Cell.

[25]  E. Kieff,et al.  DNA of Epstein-Barr virus. V. Direct repeats of the ends of Epstein-Barr virus DNA , 1979, Journal of virology.

[26]  F. Sanger,et al.  DNA sequencing with chain-terminating inhibitors. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[27]  P. Seeburg,et al.  Nucleotide sequence of part of the gene for human chorionic somatomammotropin: Purification of DNA complementary to predominant mRNA species , 1977, Cell.

[28]  P Berg,et al.  Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I. , 1977, Journal of molecular biology.

[29]  P. Leder,et al.  Purification of biologically active globin messenger RNA by chromatography on oligothymidylic acid-cellulose. , 1972, Proceedings of the National Academy of Sciences of the United States of America.

[30]  J. H. Pope,et al.  Transformation of foetal human leukocytes in vitro by filtrates of a human leukaemic cell line containing herpes‐like virus , 1968 .

[31]  M. Epstein,et al.  VIRUS PARTICLES IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMA. , 1964, Lancet.

[32]  P. Farrell,et al.  Novel nuclear antigens recognized by human sera in lymphocytes latently infected by Epstein-Barr virus. , 1987, Virology.

[33]  G. Miller,et al.  Release of infectious Epstein-Barr virus by transformed marmoset leukocytes. , 1973, Proceedings of the National Academy of Sciences of the United States of America.